Alexion Pharmaceuticals Inc (USD)
ALXN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range88.92 | 92.11
52-Wk Range |
Last Close89.77
Mkt Cap (m)19,937.92
Dividend yield-
ISINUS0153511094
Volume1,693,879
Exchange VenueNAS

Company Profile

Alexion Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

Key Information
Price/Earning8.39
Price/Book1.77
Price/Sales4.04
P/CF9.68
Rev Growth (3 year avg)17.41
EPS Growth (3 year avg)0.83
Operating Margin % 42.87
Net Margin %48.17
Return on Equity23.53
Debt/Equity0.24

Documents

Prospectus
en 13/08/2015
Annual Report
en 31/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)2,2342,6043,0843,5514,1314,991
Operating Income (m)9166827938041,5952,140
Net Income (m)657144399443782,404
Basic EPS3.320.681.781.980.3510.77
Avg. Diluted Shares Outstanding (m)202216227225225225
Balance Sheet
USD201420152016201720182019
Current Assets (m)2,7962,4252,5782,9543,3855,076
Non Current Assets (m)1,40610,70810,67510,62910,54712,468
Total Assets (m)4,20213,13313,25313,58313,93217,545
Current Liabilities (m)6077188239531,1741,194
Total Liabilities (m)------
Total Equity (m)3,3028,2598,6948,8939,16511,272
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)6406751,0861,1164262,085
Capital Expenditure (m)-137-286-333-357-213-171
Figures are quoted in USD unless stated otherwise
-
No change
$
89.77
Last Price